To Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria
Clinical trial NCT04426890 · COMPLETED
Trial details
- NCT number
- NCT04426890
- Sponsor
- Celltrion
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-09
- Primary completion
- 2022-10-21
- Enrollment
- 634
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.